Clinical Trials

Our Clinical Trials articles highlight top clinical trials, their results, and how patients can participate in them.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

New Clinical Trial with Armored CAR T-cells

October 01, 2024

Understanding CAR T-Cell Therapy and the Armored CAR T-Cell Trial

What are Clinical Trials, and How May They Help Me?

September 30, 2024

Learn about clinical trials to open the door to accessing innovative cancer treatments.

BTK Degrader for R/R CLL/SLL Receives FDA Fast Track Designation

September 06, 2024

Learn how BTK degrader BGB-16673 can aid in managing CLL/SLL if you've previously taken BTK inhibitors and venetoclax.

Zanubrutinib + Venetoclax for High-Risk First-Time Treated CLL

August 23, 2024

Learn how zanubrutinib and venetoclax helped high-risk CLL patients with del(17p)/TP53 mutation as their first treatment from the SEQUOIA study.

“Off-the-Shelf" CAR T-Cell Therapy for CLL

July 17, 2024

Learn about cem-cel, a CAR T-cell therapy made from donor T-cells that may decrease T-cell exhaustion and is more quickly available than liso-cel (Breyanzi).

First-Time Treated CLL? Learn About the New Combination of Pirtobrutinib + Obinutuzumab

April 17, 2024

Dr. Inhye Ahn is conducting a clinical trial utilizing pirtobrutinib combined with obinutuzumab for CLL patients needing treatment for the first time.

A Personalized CLL Vaccine Being Studied for Patients in Watch and Wait: NeoVax

April 15, 2024

Dr. Inhye Ahn from Dana-Farber Cancer Institute is conducting a clinical trial that administers a personalized vaccine for CLL called NeoVax.

New CLL Medicines in Clinical Trials: BTK Degraders

April 10, 2024

Learn about BTK degraders, a new type of CLL medicine in clinical trials that help overcome treatment resistance.

CLL Medicines in Clinical Trials: Epkinly

March 25, 2024

Learn about how the medicine Epkinly is helping high-risk CLL patients inside of a clinical trial.

MSK’s Clinical Trial: Reversing CAR T-cell Exhaustion with Antioxidants

May 31, 2023

Dr. Gunjan L. Shah and her team at MSK in NY are conducting a clinical trial to reverse T-cell exhaustion by pairing antioxidants alongside CAR T-cell therapy.